危险系数
医学
肝细胞癌
精制谷物
比例危险模型
碳水化合物
置信区间
低风险
内科学
食品科学
生物
全谷物
作者
Yue Liu,Wanshui Yang,Trang VoPham,Yanan Ma,Tracey G. Simon,Xiang Gao,Andrew T. Chan,Jeffrey A. Meyerhardt,Edward Giovannucci,Xuehong Zhang
出处
期刊:Hepatology
[Wiley]
日期:2021-01-01
卷期号:73 (1): 175-185
被引量:18
摘要
Little is known about the role of low-carbohydrate diets (LCDs) in the development of hepatocellular carcinoma (HCC). We prospectively evaluated the associations between plant-based and animal-based LCDs and risk of HCC in the Nurses' Health Study (NHS) and the Health Professionals Follow-up Study (HPFS).Dietary intake was assessed every 4 years using validated food frequency questionnaires. Cox proportional hazards regression models were used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs). HRs are shown for a 1-standard deviation (SD) increment with variables modeled as continuous. During 3,664,769 person-years of follow-up, there were 156 incident HCC cases. Although there were no associations between overall or animal-based LCD score and risk of HCC, plant-based LCD score was inversely associated with HCC risk (HR, 0.83; 95% CI, 0.70-0.98; Ptrend = 0.03). Carbohydrate intake, especially from refined grains (HR, 1.18; 95% CI, 1.00-1.39; Ptrend = 0.04), was positively, while plant fat (HR, 0.78; 95% CI, 0.65-0.95; Ptrend = 0.01) was inversely associated with HCC risk. Substituting 5% of energy from plant fat and protein for carbohydrate (HR, 0.74; 95% CI, 0.58-0.93; Ptrend = 0.01) or refined grains (HR, 0.70; 95% CI, 0.55-0.90; Ptrend = 0.006) was associated with lower HCC risk. In conclusion, a plant-based LCD and dietary restriction of carbohydrate from refined grains were associated with a lower risk of HCC. Substituting plant fat and protein for carbohydrate, particularly refined grains, may decrease HCC incidence.Our findings support a potential benefit in emphasizing plant sources of fat and protein in the diet for HCC primary prevention; additional studies that carefully consider hepatitis B and C virus infections and chronic liver diseases are needed to confirm our findings.
科研通智能强力驱动
Strongly Powered by AbleSci AI